Quantitative real time PCR analysis of apoptotic gene expression in chronic lymphocytic leukemia patients and their relationships with chemosensitivity

Table 3 Relative BCL2 and p53 gene expression in CLL patients (treated and untreated) according to disease duration from diagnosis date, data expressed as Mean ± SEM

Duration of disease	No. of Patient	BCL2 expression	P value	P53 expression	P value
ND	3	19.3 ± 14.0	0.054	0.16 ± 0.15	0.80
6 months	10	5.2 ± 2.29	0.418	0.11 ± 0.05	0.983
7-12 months	6	1.3 ± 0.69	0.718	0.15 ± 0.12	0.995
18 months	9	6.7 ± 2.66	0.532	0.16 ± 0.06	0.789
19–24 months	7	2.3 ± 0.86	0.656	0.10 ± 0.04	0.143
24–30 months	7	7.2 ± 3.56	0.559	0.45 ± 0.23	0.781
31–36 months	7	7.8 ± 4.74	0.864	0.21 ± 0.05	0.896
>36 months	6	6.0 ± 3.15	0.573	0.18 ± 0.10	0.763